John Jacobs
Chief Executive Officer chez NOVAVAX, INC.
Fortune : 212 934 $ au 29/02/2024
Profil
Presently, John C.s Jacobs is Co-President, Chief Executive Officer & Director at Novavax, Inc. Mr. Jacobs is also on the board of Life Sciences Pennsylvania.
He previously held the position of President, Chief Executive Officer & Director at Harmony Biosciences Holdings, Inc. and President & Chief Executive Officer at Harmony Biosciences LLC (a subsidiary of Harmony Biosciences Holdings, Inc.) and Senior VP & GM-Respiratory Business Unit at Teva Pharmaceutical Industries Ltd.
John C.s Jacobs received an undergraduate degree from State University of New York College at Plattsburgh and an MBA from State University of New York at Binghamton.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NOVAVAX, INC.
0,04% | 01/03/2024 | 43 104 ( 0,04% ) | 212 934 $ | 29/02/2024 |
Postes actifs de John Jacobs
Sociétés | Poste | Début |
---|---|---|
NOVAVAX, INC. | Chief Executive Officer | 23/01/2023 |
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Director/Board Member | 06/05/2021 |
Anciens postes connus de John Jacobs
Sociétés | Poste | Fin |
---|---|---|
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Chief Executive Officer | 23/01/2023 |
HARMONY BIOSCIENCES HOLDINGS, INC. | Chief Executive Officer | 06/01/2023 |
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/10/2017 |
Formation de John Jacobs
State University of New York College at Plattsburgh | Undergraduate Degree |
State University of New York at Binghamton | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
NOVAVAX, INC. | Health Technology |
HARMONY BIOSCIENCES HOLDINGS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Life Sciences Pennsylvania
Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Commercial Services |
Harmony Biosciences LLC
Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |